Technologies Reshaping Diabetes Management

In the past, managing type 1 or type 2 diabetes was a constant challenge — manual monitoring, frequent blood tests, and daily treatment adjustments. Today, thanks to breakthrough developments in both hardware and software, more people are gaining better control, reducing complications, and experiencing greater day-to-day confidence.  

Here are some of the key technologies leading the way. 

CGM Systems for Continuous Monitoring and Smarter Insights 

Continuous glucose monitoring (CGM) has become a cornerstone of day-to-day diabetes management, especially for people with type 1 diabetes, but increasingly for those with type 2 as well. The latest CGM devices, like the Dexcom G7 and FreeStyle Libre 3, offer real-time readings, smartphone integration, and alerts for both low and high blood sugar, helping reduce the risk of severe events like DKA (diabetic ketoacidosis). 

Studies show that CGM use improves time in range (TIR) and lowers A1C levels. 

Smarter Insulin Pumps, Reducing Decision-Making Stress 

The latest generation of insulin pumps, like the Tandem t:slim X2 and Omnipod 5, deliver more precise dosing, micro-bolus features, and direct communication with CGM devices. They offer users more flexibility and help reduce the burden of constant decision-making around insulin delivery. And they’re suitable for people with type 1 or type 2 diabetes. 

Closed-Loop Systems, Acting as an Artificial Pancreas 

Closed-loop insulin delivery systems, like Tandem Control-IQ+, Medtronic MiniMed 780G, and Beta Bionics iLet Bionic Pancreas, are transforming diabetes care by maintaining glucose levels with minimal user input. Control-IQ+ enhances this technology with key features, such as automated insulin adjustments every five minutes, AutoBolus for missed meal corrections, and the ability to deliver extended boluses for up to 8 hours — ideal for prolonged eating or delayed glucose rises. 

These systems are easy to personalize, and they’re suitable for children and adults alike. They may offer improved glucose control, fewer adverse events, and improved sleep — all of which may help reduce the daily burden of diabetes management. 

In a recent study, children under age 7 using the Medtronic MiniMed 780G system maintained an average A1C of 6.9% and spent nearly 70% of the time in range, with a notable reduction in hypoglycemic episodes. 

Telemedicine and Remote Monitoring for Customized Care 

Remote healthcare has become more standard. For people with diabetes, sharing pump and CGM data with their care teams enables them to receive more personalized feedback and get more frequent treatment adjustments. Research shows that telemedicine helps people stick to their treatment plans — especially in busy or remote populations. 

Digital Health Apps: Diabetes Management in Your Pocket 

Apps like Dario Health allow members to track glucose, meals, activity, and medications in one platform. Get personalized insights and even access to coaching or professional support. 

Studies suggest that these digital health tools help users follow their treatment plans more consistently — taking medications as prescribed, monitoring blood glucose regularly, and making recommended lifestyle changes. They also improve users’ ability to understand their glucose trends and how daily habits affect their levels.   

AI, Detecting Complications Early 

Artificial intelligence (AI) can help with early detection of diabetes-related complications. For example, it can identify the risk of kidney disease before standard tests show any signs. In children and teens with type 1 diabetes, smart systems can predict low blood sugar (hypoglycemia) up to an hour in advance, helping to prevent it — especially during the night. 

The combination of smart hardware that monitors, calculates, and delivers insulin — and smart software that learns, predicts, and guides — creates a new, more efficient, and personalized reality for people living with diabetes. If you’re not yet using advanced technology and have interest, talk with your healthcare provider about which tools might fit into your daily routine. 

 

References

https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2024.1465800/full 

https://www.thelancet.com/journals/landia/article/PIIS2213-8587(24)00284-5/fulltext 

https://link.springer.com/article/10.1007/s11892-021-01423-2 

https://pubmed.ncbi.nlm.nih.gov/39494781/ 

https://pubmed.ncbi.nlm.nih.gov/31569548/ 

https://pubmed.ncbi.nlm.nih.gov/31413285/ 

https://pubmed.ncbi.nlm.nih.gov/32476492/ 

https://diabetesjournals.org/care/article/47/10/1778/157058/Closed-Loop-Insulin-Therapy-for-People-With-Type-2 

https://diabetesjournals.org/care/article/46/11/1916/153534/Fully-Closed-Loop-Glucose-Control-Compared-With -Type-2 

https://www.umassmed.edu/globalassets/diabetes-center-of-excellence-dcoe/images/management-and-care/insulin_pump_comparison_06-17-24.pdf 

https://www.umassmed.edu/globalassets/diabetes-center-of-excellence-dcoe/images/management-and-care/cgm_comparison_chart_1024_10-16-24.pdf 

https://www.amsldiabetes.com.au/tslim-x2-insulin-pump/ 

https://www.adces.org/education/danatech/insulin-pumps/find-and-compare-insulin-pumps/product-detail/t-slim-x2-with-control-iq 

(PDF) The Impact of Digital Health on Patient Adherence to Treatment 

 

DAR-0364 RevA 

 

 

Medical Disclaimer

The articles provided on this website are for informational purposes only. In addition, it is written for a generic audience and not a specific case; therefore, this information should not be used for diagnostic or medical treatment. This site does not attempt to replace the patient-physician relationship and fully recommends the reader to seek out the best care from his/her physician and/or diabetes educator.